Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 211Neoplasm Metastasis 16Neoplasms 9Breast Neoplasms, Male 7Breast Diseases 7Ovarian Neoplasms 4Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Breast Cancer Metastatic 3Advanced Breast Cancer 3Recurrence 2Prostatic Neoplasms 2Neoplasms by Site 2Carcinoma, Renal Cell 2Bulbo-Spinal Atrophy, X-Linked 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Skin Diseases 1Sexuality 1Sexual Dysfunctions, Psychological 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Primary Breast Cancer ER+ve 1

Interventions

exemestane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metastatic Beast Cancer × exemestane × Clear all
NCT01963481 2020-03-17

Exemestane and Cyclophosphamide for Metastatic Breast Cancer

NYU Langone Health

Phase 2 Completed
23 enrolled 10 charts

Metastatic Beast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡